News
KMDA
8.28
+0.85%
0.07
Weekly Report: what happened at KMDA last week (0202-0206)?
Weekly Report · 19h ago
Weekly Report: what happened at KMDA last week (0126-0130)?
Weekly Report · 02/02 09:37
Weekly Report: what happened at KMDA last week (0119-0123)?
Weekly Report · 01/26 09:38
Weekly Report: what happened at KMDA last week (0112-0116)?
Weekly Report · 01/19 09:41
Weekly Report: what happened at KMDA last week (0105-0109)?
Weekly Report · 01/12 09:40
Hubspot Stock Set to Rise, Says Analyst. Plus, McGraw Hill, UHS, and More Stocks.
Barron‘s · 01/09 22:07
Kamada 2025/2026 Outlook: Evaluating Revenue Growth And Product Drivers
Seeking Alpha · 01/08 14:34
Kamada: Core Business Resilience and Strategic Expansion Support Buy Rating and $13 Price Target Despite Pipeline Setbacks
TipRanks · 01/08 11:46
Kamada forecasts double-digit profitable growth in 2026
Seeking Alpha · 01/07 16:49
Kamada Sets 2026 Revenue and EBITDA Guidance Above 2025 Outlook, Affirms Current-Year Targets
TipRanks · 01/07 12:27
Kamada Sees FY2026 Sales $200.000M-$205.000M vs $200.598M Est
Benzinga · 01/07 12:21
Kamada Affirms FY2025 Sales Guidance of $178.000M-$182.000M vs $181.137M Est
Benzinga · 01/07 12:21
Kamada sees FY26 revenue $200M-$205M
TipRanks · 01/07 12:05
Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance
Barchart · 01/07 06:00
Weekly Report: what happened at KMDA last week (1229-0102)?
Weekly Report · 01/05 09:38
Weekly Report: what happened at KMDA last week (1222-1226)?
Weekly Report · 12/29/2025 09:37
Weekly Report: what happened at KMDA last week (1215-1219)?
Weekly Report · 12/22/2025 09:37
Midday Fly By: Micron reports Q1 beat, Trump Media to merge with TAE
TipRanks · 12/18/2025 17:06
Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender
TipRanks · 12/18/2025 12:27
Kamada reiterates FY25 revenue guidance $178M-$182M
TipRanks · 12/18/2025 12:22
More
Webull provides a variety of real-time KMDA stock news. You can receive the latest news about Kamada Ltd through multiple platforms. This information may help you make smarter investment decisions.
About KMDA
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.